Reaction Details |
| Report a problem with these data |
Target | Thioredoxin reductase 1, cytoplasmic |
---|
Ligand | BDBM50576851 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2128404 (CHEMBL4837833) |
---|
IC50 | 13±n/a nM |
---|
Citation | Ayoup, MS; Abu-Serie, MM; Abdel-Hamid, H; Teleb, M Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy. Eur J Med Chem220:0 (2021) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Thioredoxin reductase 1, cytoplasmic |
---|
Name: | Thioredoxin reductase 1, cytoplasmic |
Synonyms: | GRIM-12 | GRIM12 | Gene associated with retinoid-IFN-induced mortality 12 protein | KDRF | KM-102-derived reductase-like factor | TR | TRXR1_HUMAN | TXNRD1 | Thioredoxin reductase 1 | Thioredoxin reductase 1 (TrxR) | Thioredoxin reductase TR1 |
Type: | Protein |
Mol. Mass.: | 70761.78 |
Organism: | Homo sapiens (Human) |
Description: | Q16881 |
Residue: | 648 |
Sequence: | MGCAEGKAVAAAAPTELQTKGKNGDGRRRSAKDHHPGKTLPENPAGFTSTATADSRALLQ
AYIDGHSVVIFSRSTCTRCTEVKKLFKSLCVPYFVLELDQTEDGRALEGTLSELAAETDL
PVVFVKQRKIGGHGPTLKAYQEGRLQKLLKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKE
AAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKV
EETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEK
IYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLA
GIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVV
AQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIY
AIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKA
VEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQ
GFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCG
|
|
|
BDBM50576851 |
---|
n/a |
---|
Name | BDBM50576851 |
Synonyms: | CHEMBL1876217 |
Type | Small organic molecule |
Emp. Form. | C14H10N2O2 |
Mol. Mass. | 238.2414 |
SMILES | Oc1ccccc1-c1nc(no1)-c1ccccc1 |
Structure |
|